|
|
|
Insider
Information: |
Schimmel Paul |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,717,702 |
|
Indirect Shares
|
1,312,785 |
|
|
Direct
Value |
$117,111,431 |
|
|
Indirect Value
|
$45,631,905 |
|
|
Total
Shares |
3,030,487 |
|
|
Total
Value |
$162,743,336 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2018-03-13 |
0 |
2018-03-13 |
306,996 |
Premium* |
|
Repligen Corp |
RGEN |
Director |
2007-06-14 |
665,106 |
2005-11-07 |
0 |
Premium* |
|
Avicena Group, Inc. |
AVCE |
Director |
2006-12-28 |
1,020,242 |
2005-11-23 |
0 |
Premium* |
|
aTyr Pharma Inc |
LIFE |
Director |
2023-05-10 |
8,890 |
2023-05-10 |
992,166 |
Premium* |
|
Forte Biosciences Inc |
FBRX |
Director |
2017-04-19 |
23,464 |
2017-04-19 |
13,623 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
206,315 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2004-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,578 |
237,893 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2005-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
121 |
238,014 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2005-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
74 |
238,088 |
|
- |
|
RGEN |
Repligen Corp |
Director |
|
2005-11-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,576 |
658,106 |
|
- |
|
AVCE |
Avicena Group, Inc. |
Director |
|
2005-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
33,242 |
1,205,242 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2006-02-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,615 |
336,473 |
0 |
- |
|
RGEN |
Repligen Corp |
Director |
|
2006-08-11 |
4 |
OE |
$0.88 |
$4,400 |
D/D |
5,000 |
663,106 |
|
- |
|
AVCE |
Avicena Group, Inc. |
Director |
|
2006-12-28 |
5 |
GD |
$0.00 |
$0 |
D/D |
185,000 |
1,020,242 |
0 |
- |
|
RGEN |
Repligen Corp |
Director |
|
2007-02-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
660,106 |
0 |
- |
|
RGEN |
Repligen Corp |
Director |
|
2007-06-14 |
4 |
OE |
$1.00 |
$5,000 |
D/D |
5,000 |
665,106 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2007-11-30 |
4 |
S |
$33.50 |
$673,957 |
D/D |
(20,000) |
238,088 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2007-11-30 |
4 |
S |
$32.90 |
$569,177 |
I/I |
(17,222) |
81,163 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2007-11-30 |
4 |
OE |
$7.08 |
$218,200 |
D/D |
20,000 |
258,088 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2007-12-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
234,088 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2007-12-03 |
4 |
S |
$32.30 |
$377,669 |
I/I |
(11,586) |
69,577 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2007-12-04 |
4 |
S |
$31.85 |
$229,364 |
I/I |
(7,192) |
62,385 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2009-09-04 |
4 |
S |
$22.02 |
$647,482 |
D/D |
(29,400) |
204,688 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2009-09-09 |
4 |
S |
$22.10 |
$662,931 |
D/D |
(30,000) |
174,688 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2009-09-10 |
4 |
S |
$22.26 |
$347,289 |
D/D |
(15,600) |
159,088 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2013-10-22 |
4 |
AS |
$60.00 |
$900,000 |
D/D |
(15,000) |
126,216 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2013-10-22 |
4 |
OE |
$9.30 |
$139,500 |
D/D |
15,000 |
141,216 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2013-12-20 |
4 |
AS |
$65.00 |
$975,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2013-12-20 |
4 |
OE |
$11.33 |
$169,950 |
D/D |
15,000 |
15,000 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Director |
|
2013-12-26 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,500 |
310,996 |
0 |
- |
|
84 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|